Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-13 Sale(A) | 2023-03-27 8:12 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 100 | $13.25 | $1,325 | 555,084 (Direct) | View |
| 2021-12-13 Sale | 2022-12-15 7:07 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 100 | $13.25 | $1,325 | 555,084 (Direct) | View |
| 2022-12-02 Sale | 2022-12-06 6:29 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 1,100 | $13.25 | $14,575 | 591,978 (Direct) | View |
| 2022-12-01 Sale | 2022-12-02 4:00 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 5,000 | $13.36 | $66,788 | 593,078 (Direct) | View |
| 2022-11-16 Sale | 2022-11-17 6:21 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 300 | $13.25 | $3,976 | 598,078 (Direct) | View |
| 2022-11-10 Sale | 2022-11-14 6:43 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 24,410 | $13.29 | $324,529 | 598,378 (Direct) | View |
| 2022-09-14 Sale | 2022-09-16 7:07 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 8,305 | $13.26 | $110,084 | 622,788 (Direct) | View |
| 2022-09-09 Sale | 2022-09-13 4:07 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 23,991 | $13.31 | $319,282 | 631,093 (Direct) | View |
| 2021-12-09 Sale | 2021-12-13 6:06 pm | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 25,000 | $12.67 | $316,763 | 655,084 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-01 Option Award | 2023-06-05 5:36 pm | N/A 2033-06-01 | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 56,322 | $0 | 56,322 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:02 pm | N/A 2032-06-01 | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 30,549 | $0 | 685,633 (Direct) | View |
| 2021-05-21 Option Award | 2021-05-25 9:53 pm | N/A 2031-05-21 | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 16,860 | $0 | 696,944 (Direct) | View |
Ownership(A) | 2021-04-21 9:38 pm | N/A N/A | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 0 | $0 | 723,002 (Direct) | View |
Ownership | 2021-04-20 7:48 pm | N/A N/A | Akoya Biosciences Inc. | AKYA | Nolan Garry Ph.D. Director | 0 | $0 | 723,002 (Direct) | View |